Josane F Sousa1, Ki Taek Nam2, Christine P Petersen1, Hyuk-Joon Lee3, Han-Kwang Yang3, Woo Ho Kim4, James R Goldenring1. 1. Nashville VA Medical Center and the Epithelial Biology Center and Section of Surgical Sciences, Vanderbilt University School of Medicine, Nashville, Tennessee, USA. 2. Nashville VA Medical Center and the Epithelial Biology Center and Section of Surgical Sciences, Vanderbilt University School of Medicine, Nashville, Tennessee, USA Severance Biomedical Science Institute, Seoul, Korea Brain Korea 21 PLUS Project for Medical Science, Yonsei University College of Medicine, Seoul, Korea. 3. Department of Surgery, Seoul National University College of Medicine, Seoul, Korea Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea. 4. Department of Pathology, Seoul National University College of Medicine, Seoul, Korea.
Abstract
OBJECTIVE: Intestinal metaplasia and spasmolytic polypeptide-expressing metaplasia (SPEM) are considered neoplastic precursors of gastric adenocarcinoma and are both marked by gene expression alterations in comparison to normal stomach. Since miRNAs are important regulators of gene expression, we sought to investigate the role of miRNAs on the development of stomach metaplasias. DESIGN: We performed miRNA profiling using a quantitative reverse transcription-PCR approach on laser capture microdissected human intestinal metaplasia and SPEM. Data integration of the miRNA profile with a previous mRNA profile from the same samples was performed to detect potential miRNA-mRNA regulatory circuits. Transfection of gastric cancer cell lines with selected miRNA mimics and inhibitors was used to evaluate their effects on the expression of putative targets and additional metaplasia markers. RESULTS: We identified several genes as potential targets of miRNAs altered during metaplasia progression. We showed evidence that HNF4γ (upregulated in intestinal metaplasia) is targeted by miR-30 and that miR-194 targets a known co-regulator of HNF4 activity, NR2F2 (downregulated in intestinal metaplasia). Intestinal metaplasia markers such as VIL1, TFF2 and TFF3 were downregulated after overexpression of miR-30a in a HNF4γ-dependent manner. In addition, overexpression of HNF4γ was sufficient to induce the expression of VIL1 and this effect was potentiated by downregulation of NR2F2. CONCLUSIONS: The interplay of the two transcription factors HNF4γ and NR2F2 and their coordinate regulation by miR-30 and miR-194, respectively, represent a miRNA to transcription factor network responsible for the expression of intestinal transcripts in stomach cell lineages during the development of intestinal metaplasia. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/
OBJECTIVE:Intestinal metaplasia and spasmolytic polypeptide-expressing metaplasia (SPEM) are considered neoplastic precursors of gastric adenocarcinoma and are both marked by gene expression alterations in comparison to normal stomach. Since miRNAs are important regulators of gene expression, we sought to investigate the role of miRNAs on the development of stomach metaplasias. DESIGN: We performed miRNA profiling using a quantitative reverse transcription-PCR approach on laser capture microdissected humanintestinal metaplasia and SPEM. Data integration of the miRNA profile with a previous mRNA profile from the same samples was performed to detect potential miRNA-mRNA regulatory circuits. Transfection of gastric cancer cell lines with selected miRNA mimics and inhibitors was used to evaluate their effects on the expression of putative targets and additional metaplasia markers. RESULTS: We identified several genes as potential targets of miRNAs altered during metaplasia progression. We showed evidence that HNF4γ (upregulated in intestinal metaplasia) is targeted by miR-30 and that miR-194 targets a known co-regulator of HNF4 activity, NR2F2 (downregulated in intestinal metaplasia). Intestinal metaplasia markers such as VIL1, TFF2 and TFF3 were downregulated after overexpression of miR-30a in a HNF4γ-dependent manner. In addition, overexpression of HNF4γ was sufficient to induce the expression of VIL1 and this effect was potentiated by downregulation of NR2F2. CONCLUSIONS: The interplay of the two transcription factors HNF4γ and NR2F2 and their coordinate regulation by miR-30 and miR-194, respectively, represent a miRNA to transcription factor network responsible for the expression of intestinal transcripts in stomach cell lineages during the development of intestinal metaplasia. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/
Authors: Melissa S Cline; Michael Smoot; Ethan Cerami; Allan Kuchinsky; Nerius Landys; Chris Workman; Rowan Christmas; Iliana Avila-Campilo; Michael Creech; Benjamin Gross; Kristina Hanspers; Ruth Isserlin; Ryan Kelley; Sarah Killcoyne; Samad Lotia; Steven Maere; John Morris; Keiichiro Ono; Vuk Pavlovic; Alexander R Pico; Aditya Vailaya; Peng-Liang Wang; Annette Adler; Bruce R Conklin; Leroy Hood; Martin Kuiper; Chris Sander; Ilya Schmulevich; Benno Schwikowski; Guy J Warner; Trey Ideker; Gary D Bader Journal: Nat Protoc Date: 2007 Impact factor: 13.491
Authors: S Taraviras; T Mantamadiotis; T Dong-Si; A Mincheva; P Lichter; T Drewes; G U Ryffel; A P Monaghan; G Schütz Journal: Biochim Biophys Acta Date: 2000-01-31
Authors: Josane F Sousa; Amy-Joan L Ham; Corbin Whitwell; Ki Taek Nam; Hyuk-Joon Lee; Han-Kwang Yang; Woo Ho Kim; Bing Zhang; Ming Li; Bonnie LaFleur; Daniel C Liebler; James R Goldenring Journal: Am J Pathol Date: 2012-09-01 Impact factor: 4.307
Authors: Massimo Rugge; Robert M Genta; David Y Graham; Francesco Di Mario; Luiz Gonzaga Vaz Coelho; Nayoung Kim; Peter Malfertheiner; Kentaro Sugano; Vladislav Tsukanov; Pelayo Correa Journal: Gut Date: 2016-02-29 Impact factor: 23.059
Authors: C Deng; B Zhang; S Zhang; C Duan; Y Cao; W Kang; H Yan; X Ding; F Zhou; L Wu; G Duan; S Shen; G Xu; W Zhang; M Chen; S Huang; X Zhang; Y Lv; T Ling; L Wang; X Zou Journal: Cell Death Dis Date: 2016-02-18 Impact factor: 8.469